Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
Your well-being is the top priority, and open communication with your healthcare provider ensures youre receiving the best care
Some medical professionals tout and prescribe BPC-157 as a treatment for various conditions and injuries, including gastric ulcers, irritable bowel syndrome (this sounds plausible, given the role of natural BPC in our stomachs), ligament, tendon, and joint injuries, and erectile dysfunction
Individuals with NF1, those with prior radiation therapy, and adults between ages 20 and 50 are at increased risk